CCAAT-Enhancer binding protein delta (C/EBPδ) protects against klebsiella pneumoniae-induced pulmonary infection: Potential role for macrophage migration

Journal of Infectious Diseases

Volumn 206, Issue 12, 2012, Pages 1826-1835

  Duitman, Janwillem ^a,b   Hoogendijk, Arie J ^a,b   Groot, Angelique P ^a   Ruela De Sousa, Roberta R ^a   Van Der Poll, Tom ^a,b   Florquin, Sandrine ^b   Spek, C Arnold ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN DELTA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL GROWTH; BACTERIAL LOAD; BACTERIAL PNEUMONIA; CONTROLLED STUDY; IN VITRO STUDY; INFLAMMATION; KLEBSIELLA PNEUMONIAE; KLEBSIELLA PNEUMONIAE INFECTION; MACROPHAGE; MACROPHAGE MIGRATION; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SURVIVAL;

ANIMALS; BACTERIAL LOAD; CCAAT-ENHANCER-BINDING PROTEIN-DELTA; CELL MOVEMENT; DISEASE MODELS, ANIMAL; GENE EXPRESSION PROFILING; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; LUNG; MACROPHAGES; MICE; MICE, KNOCKOUT; PNEUMONIA, BACTERIAL; SURVIVAL ANALYSIS;

EID: 84870164004     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jis615     Document Type: Article

References (35)

1. Burwen DR, Banerjee SN, Gaynes RP. Ceftazidime resistance among selected nosocomial gram-negative bacilli in the United-States. J Infect Dis 1994; 170:1622-5. (Pubitemid 24369932)
2. Podschun R, Ullmann U. Klebsiella spp. as nosocomial pathogens: Epidemiology, taxonomy, typing methods, and pathogenicity factors. Clin Microbiol Rev 1998; 11:589-603. (Pubitemid 28497563)
3. Yinnon AM, Butnaru A, Raveh D, Jerassy Z, Rudensky B. Klebsiella bacteraemia: Community versus nosocomial infection. QJM 1996; 89:933-41. (Pubitemid 27016323)
4. Wheeler AP, Bernard GR. Treating patients with severe sepsis. N Engl J Med 1999; 340:207-14. (Pubitemid 29063218)
5. Lekstrom-Himes J, Xanthopoulos KG. Biological role of the CCAAT/enhancer-binding protein family of transcription factors. J Biol Chem 1998; 273:28545-8. (Pubitemid 28507532)
6. Alam T, An MR, Papaconstantinou J. Differential expression of three C/EBP isoforms in multiple tissues during the acute phase response. J Biol Chem 1992; 267:5021-4.
7. Juan TS, Wilson DR, Wilde MD, Darlington GJ. Participation of the transcription factor C/EBP delta in the acute-phase regulation of the human gene for complement component C3. Proc Natl Acad Sci U S A 1993; 90:2584-8. (Pubitemid 23113460)
8. Kinoshita S, Akira S, Kishimoto T. A member of the C/EBP family, NF-IL6 beta, forms a heterodimer and transcriptionally synergizes with NF-IL6. Proc Natl Acad Sci U S A 1992; 89:1473-6.
9. Lu YC, Kim I, Lye E, et al. Differential role for c-Rel and C/EBP beta/delta in TLR-mediated induction of proinflammatory cytokines. J Immunol 2009; 182:7212-21.
10. Hu HM, Baer M, Williams SC, Johnson PF, Schwartz RC. Redundancy of C/EBP alpha, -beta, and -delta in supporting the lipopolysaccharide- induced transcription of IL-6 and monocyte chemoattractant protein-1. J Immunol 1998; 160:2334-42. (Pubitemid 28119915)
11. Bretz JD, Williams SC, Baer M, Johnson PF, Schwartz RC. C/EBPRelated Protein-2 confers lipopolysaccharide-inducible expression of interleukin-6 and monocyte chemoattractant protein-1 to a lymphoblastic cell-line. Proc Natl Acad Sci U S A 1994; 91:7306-10. (Pubitemid 24226852)
12. Dendorfer U, Oettgen P, Libermann TA. Multiple regulatory elements in the interleukin-6 gene mediate induction by prostaglandins, cyclicamp, and lipopolysaccharide. Mol Cell Biol 1994; 14:4443-54. (Pubitemid 24196793)
13. Wedel A, Sulski G, Ziegler-Heitbrock HW. CCAAT/enhancer binding protein is involved in the expression of the tumour necrosis factor gene in human monocytes. Cytokine 1996; 8:335-41. (Pubitemid 26163103)
14. Dlaska M, Weiss G. Central role of transcription factor NF-IL6 for cytokine and iron-mediated regulation of murine inducible nitric oxide synthase expression. J Immunol 1999; 162:6171-7. (Pubitemid 29314979)
15. Beck GC, Rafat N, Brinkkoetter P, et al. Heterogeneity in lipopolysaccharide responsiveness of endothelial cells identified by gene expression profiling: Role of transcription factors. Clin Exp Immunol 2006; 143:523-33.
16. Thomas B, Berenbaum F, Humbert L, et al. Critical role of C/EBP delta and C/EBP beta factors in the stimulation of the cyclooxygenase-2 gene transcription by interleukin-1 beta in articular chondrocytes. Eur J Biochem 2000; 267:6798-809.
17. Wang JM, Ko CY, Chen LC, Wang WL, Chang WC. Functional role of NF-IL6 beta and its sumoylation and acetylation modifications in promoter activation of cyclooxygenase 2 gene. Nucleic Acids Res 2006; 34:217-31.
18. Litvak V, Ramsey SA, Rust AG, et al. Function of C/EBPdelta in a regulatory circuit that discriminates between transient and persistent TLR4-induced signals. Nat Immunol 2009; 10:437-43.
19. Slofstra SH, Groot AP, Obdeijn MH, Reitsma PH, ten Cate H, Spek CA. Gene expression profiling identifies C/EBPdelta as a candidate regulator of endotoxin-induced disseminated intravascular coagulation. Am J Respir Crit Care Med 2007; 176:602-9. (Pubitemid 47403278)
20. Sterneck E, Paylor R, Jackson-Lewis V, et al. Selectively enhanced contextual fear conditioning in mice lacking the transcriptional regulator CCAAT/enhancer binding protein delta. Proc Natl Acad Sci U S A 1998; 95:10908-13. (Pubitemid 28413167)
21. Renckens R, Roelofs JJTH, Bonta PI, et al. Plasminogen activator inhibitor type 1 is protective during severe Gram-negative pneumonia. Blood 2007; 109:1593-601.
22. Renckens R, Roelofs JJTH, Stegenga ME, et al. Transgenic tissue-type plasminogen activator expression improves host defense during Klebsiella pneumonia. J Thromb Haemost 2008; 6:660-8. (Pubitemid 351404934)
23. Bruggemann LW, Schoenmakers SH, Groot AP, Reitsma PH, Spek A. Role of the factor V Leiden mutation in septic peritonitis assessed in factor V Leiden transgenic mice. Crit Care Med 2006; 34:2201-6. (Pubitemid 44305626)
24. Slofstra SH, Bijlsma MF, Groot AP, et al. Protease-activated receptor-4 inhibition protects from multiorgan failure in a murine model of systemic inflammation. Blood 2007; 110:3176-82. (Pubitemid 350106309)
25. Knapp S, Hareng L, Rijneveld AW, et al. Activation of neutrophils and inhibition of the proinflammatory cytokine response by endogenous granulocyte colony-stimulating factor in murine pneumococcal pneumonia. J Infect Dis 2004; 189:1506-14. (Pubitemid 38543600)
26. Knapp S, Wieland CW, 't Veer C, et al. Toll-like receptor 2 plays a role in the early inflammatory response to murine pneumococcal pneumonia but does not contribute to antibacterial defense. J Immunol 2004; 172:3132-8. (Pubitemid 38263703)
27. van der Windt G, Hoogerwerf J, de Vos A, Florquin S, Van der Poll T. Osteopontin promotes host defense during Klebsiella pneumoniaeinduced pneumonia. Eur Respir J 2010; 36:1337-45.
28. van Zoelen MAD, Schouten M, de Vos AF, et al. The receptor for advanced glycation end products impairs host defense in pneumococcal pneumonia. J Immunol 2009; 182:4349-56.
29. Duitman J, Schouten M, Groot AP, et al. CCAAT/enhancer-binding protein delta facilitates bacterial dissemination during pneumococcal pneumonia in a platelet-activating factor receptor-dependent manner. Proc Natl Acad Sci U S A 2012; 109:9113-8.
30. Hu HM, Tian Q, Baer M, et al. The C/EBP bZIP domain can mediate lipopolysaccharide induction of the proinflammatory cytokines interleukin- 6 and monocyte chemoattractant protein-1. J Biol Chem 2000; 275:16373-81. (Pubitemid 30366955)
31. BrougHolub E, Toews GB, VanIwaarden JF, et al. Alveolar macrophages are required for protective pulmonary defenses in murine Klebsiella pneumonia: Elimination of alveolar macrophages increases neutrophil recruitment but decreases bacterial clearance and survival. Infect Immun 1997; 65:1139-46. (Pubitemid 27146594)
32. Iles KE, Forman HJ. Macrophage signaling and respiratory burst. Immunol Res 2002; 26:95-105. (Pubitemid 35177488)
33. Martinez FO, Sica A, Mantovani A, Locati M. Macrophage activation and polarization. Front Biosci 2008; 13:453-61. (Pubitemid 351599757)
34. Mizgerd JP. Mechanisms of disease: Acute lower respiratory tract infection. N Engl J Med 2008; 358:716-27. (Pubitemid 351240751)
35. Strieter RM, Belperio JA, Keane MP. Cytokines in innate host defense in the lung. J Clin Invest 2002; 109:699-705. (Pubitemid 34263143)